Cancer Screening

Opportunity Overview

• Founded with a mission to develop affordable medical devices based on biophotonics and allied technologies for social impact.
• Has developed a bimodal multispectral imaging technology for screening and early detection of epithelial cancers that can be adapted for both oral and cervical cancer detection.
• ISO13485:2016 certified and the R&D unit of the company is recognized by the DSIR, Govt of India.
• Oral and Cervical cancers have high prevalence over the world, with mortality rates in excess of 50%. This primarily due to the fact that the disease is getting detected during the late stages of its development.

Key Investment Highlights

• OralCancer - TAM: $7.3 Bn, SAM: $3.5 Bn and SOM: $210 Mn
• Cervical Cancer - TAM: $ 10 Bn, SAM: $5 Bn and SOM: $400 Mn
• Diabetic Foot Ulcers: TAM: $4.3 Bn , SAM: $ 2 Bn, and SOM: $200 Mn
• Asking investment range - US$ 2-3 mn
• Terms - CCPS / pre money valuation US$ 20 mn